Philips Medical Systems is evolving the concept of PACS to a three-dimensional plane. The Dutch company plans to feature its iSite PACS as common ground for bringing together its digital imaging technologies at the RSNA meeting.
Philips Medical Systems is evolving the concept of PACS to a three-dimensional plane. The Dutch company plans to feature its iSite PACS as common ground for bringing together its digital imaging technologies at the RSNA meeting.
Arguably, this has been the goal of PACS from the beginning. But over the years other functions of PACS have taken priority, as these systems have been defined in terms of archiving and transmitting data, not connecting modalities.
"Interfacing and networking will kill you as you move into digital technologies," said Scott Burkhart, vice president of Philips general x-ray. "What we are doing is taking that out of the equation and making sure all our stuff is seamless."
The spur for this move came from the x-ray side of the business. Philips, like GE, Toshiba, and other vendors, is taking digital radiography into three dimensions, as rotational studies are providing the foundation for volumetric reconstructions.
Last year Philips introduced the MultiDiagnost Eleva R/F (radiography/fluoroscopy) system, capable of doing 180° scans. The C-arm-based product was configured with a 3D workstation to reconstruct the data. This year the company wants to take these acquisitions into the multimodality arena via iSite.
"We will be able to take a general x-ray 3D image and compare it to a 3D CT image and compare that to 3D MR imaging," Burkhart said.
This unification of the 3D world will improve workflow by melding digital modalities. The tool for doing so is a PACS component called iSyntax, which sends requested data from the iSite PACS to viewers on the network.
"It pushes out as much information as you need to see," he said. "It makes the deployment of medical imagery much more seamless and fluid."
This communications platform has the potential to transform the digital workspace into an environment that can accept a multimodality view of medicine, according to Burkhart.
"Once they make the mental shift from 2D to 3D, nobody will want to go back," he said.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.